Eli Lilly to withdraw advice leaflet
December 21st, 2007 Posted by: Dr. Cox
The Medicines and Healthcare products Regulatory Agency (MHRA) has forced Eli Lilly to withdraw an advice leaflet. The leaflet, providing doctors with advice on treatments for mental health, was written on behalf of Diabetes UK and carried the logo of the charity, reports the Financial Times.
However, Eli Lilly admitted that it omitted to include that it had sponsored the leaflet, calling the mistake an oversight. The firm was also criticised for not making the risk of schizophrenia medicines clear, including its own drug Zyprexa (olanzapine), to people suffering from hyperglycaemia and diabetes. The MHRA has called for Eli Lilly to withdraw the information, originally distributed in 2003, although it was removed in May last year by the firm.
© Adfero Ltd
Disclaimer
AllAboutMedicalSales excludes any warranty, express or implied, as to the quality, accuracy, timeliness, completeness or fitness for a particular purpose of this briefing. AllAboutMedicalSales will not be liable for any claims, penalties, losses, damages, costs, or expenses arising from the use of or inability to use this briefing or from any unauthorised access to or alteration of the Briefing. AllAboutMedicalSales makes no warranty that the contents of this briefing are compatible with all computer systems and browsers.